GoodRx Holdings, Inc. Annual Income Tax Expense (Benefit) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
GoodRx Holdings, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2018 to 2023.
  • GoodRx Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $4.15M.
  • GoodRx Holdings, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $11.6M.
  • GoodRx Holdings, Inc. annual Income Tax Expense (Benefit) for 2023 was -$46.7M, a 587% decline from 2022.
  • GoodRx Holdings, Inc. annual Income Tax Expense (Benefit) for 2022 was $9.6M, a 36.3% decline from 2021.
  • GoodRx Holdings, Inc. annual Income Tax Expense (Benefit) for 2021 was $15.1M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$46.7M -$56.3M -587% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $9.6M -$5.48M -36.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $15.1M +$24.9M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$9.83M -$26.8M -158% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $16.9M +$8.38M +97.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $8.56M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.